This funding supports extramural research investigating challenges in clinical assay development caused by preanalytical variability in tumor biopsies, blood liquid biopsies, and other biospecimens. Funded projects will explore how biospecimen collection, processing, and storage affect biomarker quantification across various testing platforms, aiming to standardize biopsy handling and expedite assay development.
Eligible applicants include a wide range of U.S. organizations such as city and state governments, small businesses, nonprofits, tribal governments, and institutions of higher education. Specific eligibility details are provided in the funding notice.
